TY - JOUR
T1 - Optimizing Donor Kidneys During Normothermic Machine Perfusion With Sevoflurane
T2 - Design of a Research Model
AU - Günkel, Philip N.
AU - Yang, Shuqi
AU - Tuinhout, Rozemarijn S.
AU - Luttik, Sebastiaan J.
AU - Hoffmann, Roland F.
AU - Ottens, Petra J.
AU - Richard, Damien
AU - Jabaudon, Matthieu
AU - Struys, Michel M.R.F.
AU - Leuvenink, Henri G.D.
AU - Nieuwenhuijs-Moeke, Gertrude J.
N1 - Publisher Copyright:
© 2025 The Author(s). Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.
PY - 2025/10/13
Y1 - 2025/10/13
N2 - Normothermic machine perfusion (NMP) of donor kidneys provides an opportunity not only for organ preservation but also for therapeutic intervention to reduce ischemia–reperfusion injury (IRI) and support tissue repair. Sevoflurane, a volatile anesthetic known to protect against IRI in other organ systems, has not previously been explored in the context of kidney NMP. This study aimed to establish a stable and reproducible porcine kidney NMP model incorporating sevoflurane delivery. Different administration techniques and oxygenator setups were evaluated to identify the most effective method of sevoflurane application. Administering sevoflurane directly as a liquid into the perfusate resulted in excessive gas formation and unstable drug concentrations. In contrast, using a vaporizer connected to an Inspire 8F M oxygenator allowed for stable and reproducible sevoflurane levels over a 90-min perfusion period, while maintaining sufficient oxygenation. This method proved to be a reliable approach for sevoflurane delivery in kidney NMP. However, oxygenators exposed to sevoflurane should not be reused due to the risk of membrane damage. These findings support the feasibility of using sevoflurane in kidney NMP and provide a platform for further investigation into its potential to improve renal graft outcomes.
AB - Normothermic machine perfusion (NMP) of donor kidneys provides an opportunity not only for organ preservation but also for therapeutic intervention to reduce ischemia–reperfusion injury (IRI) and support tissue repair. Sevoflurane, a volatile anesthetic known to protect against IRI in other organ systems, has not previously been explored in the context of kidney NMP. This study aimed to establish a stable and reproducible porcine kidney NMP model incorporating sevoflurane delivery. Different administration techniques and oxygenator setups were evaluated to identify the most effective method of sevoflurane application. Administering sevoflurane directly as a liquid into the perfusate resulted in excessive gas formation and unstable drug concentrations. In contrast, using a vaporizer connected to an Inspire 8F M oxygenator allowed for stable and reproducible sevoflurane levels over a 90-min perfusion period, while maintaining sufficient oxygenation. This method proved to be a reliable approach for sevoflurane delivery in kidney NMP. However, oxygenators exposed to sevoflurane should not be reused due to the risk of membrane damage. These findings support the feasibility of using sevoflurane in kidney NMP and provide a platform for further investigation into its potential to improve renal graft outcomes.
UR - https://www.scopus.com/pages/publications/105018680805
U2 - 10.1111/aor.70035
DO - 10.1111/aor.70035
M3 - Article
C2 - 41081384
AN - SCOPUS:105018680805
SN - 0160-564X
JO - Artificial Organs
JF - Artificial Organs
ER -